Peter,
Actually, I have not gotten back in, but I have thought about it. I am waiting for a drop. Recently it went to about $21 or so and I was following it but it recovered a bit. Had the stock gone done significantly more, I would get in. My first purchase was at $13 1/2 and I sold at $24. I sold becuase I felt it was overvalued.
I still like this company. Losing money is irrelevant in this sector - it's all speculation over future products. FRom what I know of INHL, their technology for delivery of powders via inhalation is extremely promising and they have many collaborations. In my opinion, again only opinion, there current price reflects one of these collaborations yielding a product. If, say, one or more additional projects were successful, then it would go higher. The real wildcard here is the insulin trial, becuase of the huge market for this drug. Curiously, I haven't heard much about what is going on there. If I do here very positive news, I would probably buy back in, even at these levels, but it might be too late.
Rick |
